Vol. 6 No. 2 (2026): Special Issue: AI-Driven Drug Discovery and Testing Innovations: Bridging Computational Power and Clinical Translation

Special Issue on AI in drug discovery

Special Issue Title

AI-Driven Drug Discovery and Testing Innovations: Bridging Computational Power and Clinical Translation

Aims & Scope

This special issue will highlight the transformative role of artificial intelligence in accelerating and reshaping the drug discovery pipeline. We welcome contributions that explore theoretical frameworks, computational methods, experimental validations, and translational applications

Topic of Interests (but not limited to)-

  • Drug Discovery
  • Preclinical Testing
  • Data-Driven Approaches
  • Translational Applications
  • Regulatory, Ethical, and Industrial Perspectives

Types of Manuscripts Accepted

  • Original Research
  • Review Articles
  • Mini Reviews
  • Perspectives / Commentaries
  • Systematic Reviews / Meta-analyses
  • Short Communications

Important Dates

Manuscript Submission Deadline: 31 March 2026

Submission Guidelines

Visit Manuscript preparation guidelines for details.

Click here to submit to Special Issue

Note: While submitting, please choose the appropriate Article Type and mention in the Cover Letter that your manuscript is for this Special Issue.

Article Processing charge- APC Waiver availabe. Visit here for details. 

Edited by

Dr. Kusum Sharma, V Mags Global EduTech, New Delhi, India

Email: skusum1399@gmail.com

Dr. Sachchida Nand Rai, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

Email: sn.rai@bhu.ac.in

Keywords

  • AI in Drug Discovery
  • Machine Learning
  • Deep Learning
  • Computational Pharmacology
  • Predictive Toxicology
  • Precision Medicine
  • Systems Biology
  • Translational Pharmacology
  • Bioinformatics
Published: 16-11-2025